Drug · DIN 02447401
OBIZUR
SINGLE-DOSE VIAL
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since June 8, 2021; first marketed November 30, 2016.
- Drug Identification Number (DIN)
- 02447401
- Company (DIN owner)
- Takeda Canada IncorporatedToronto, Ontario, Canada
- Schedule
- Schedule D
- Dosage form
- Powder For Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Coagulation factor viii B02BD02
- Class
- Human
- Record last updated
- August 7, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ANTIHEMOPHILIC FACTOR (RECOMBINANT) PORCINE SEQUENCE | 500 UNIT | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- May 4, 2018: NOC 20830New Drug Submission (NDS) · Merger - buyout
- October 14, 2015: NOC 17370New Drug Submission (NDS)